Nana Muazin

Beyond Awareness: Global Landmarks to Shine Teal, Green, and Pink for Metastatic Breast Cancer Research beyond-awareness-global-landmarks-to-shine-teal-green-and-pink-for-metastatic-breast-cancer-research

Beyond Awareness: Global Landmarks to Shine Teal, Green, and Pink for Metastatic Breast Cancer Research

Nana Muazin October 12, 2026

NEW YORK, NY — As October marks Breast Cancer Awareness Month, the familiar landscape of pink ribbons...

A Global Beacon: #LightUpMBC Campaign Unites World to Confront Metastatic Breast Cancer

Nana Muazin October 11, 2026

NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, a poignant, multicolored glow...

Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI regulatory-shift-the-end-of-disparate-impact-enforcement-under-title-vi

Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI

Nana Muazin October 11, 2026

Introduction: A Fundamental Change in Federal Civil Rights Oversight On July 23, 2026, the Department of Health...

A New Frontier in Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation a-new-frontier-in-reproductive-medicine-eight-healthy-infants-born-via-mitochondrial-donation

A New Frontier in Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation

Nana Muazin October 10, 2026

In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...

Beyond the Diagnosis: Navigating Life After Breast Cancer Treatment beyond-the-diagnosis-navigating-life-after-breast-cancer-treatment

Beyond the Diagnosis: Navigating Life After Breast Cancer Treatment

Nana Muazin October 10, 2026

The end of active breast cancer treatment is often viewed as the finish line—a moment of profound...

Biotech Industry Weekly: Market Volatility, Regulatory Shifts, and Strategic Capital Moves biotech-industry-weekly-market-volatility-regulatory-shifts-and-strategic-capital-moves

Biotech Industry Weekly: Market Volatility, Regulatory Shifts, and Strategic Capital Moves

Nana Muazin October 10, 2026

The biotechnology sector faced a week of complex developments, characterized by intense scrutiny over drug efficacy, strategic...

A Fractured Partnership: The World Health Organization Reflects on the U.S. Withdrawal and the Lessons of the Pandemic $a-fractured-partnership-the-world-health-organization-reflects-on-the-u-s-withdrawal-and-the-lessons-of-the-pandemic$

A Fractured Partnership: The World Health Organization Reflects on the U.S. Withdrawal and the Lessons of the Pandemic

Nana Muazin October 10, 2026

Introduction The relationship between the United States and the World Health Organization (WHO) has historically been one...

FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Approval of Tucatinib Maintenance Therapy Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo

Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo

FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Approval of Tucatinib Maintenance Therapy

Nana Muazin October 10, 2026

The landscape of metastatic breast cancer (MBC) treatment has reached a significant milestone following the U.S. Food...

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-4

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Nana Muazin October 9, 2026

In a landmark achievement for reproductive science and genomic medicine, researchers at Newcastle University and The Newcastle...

Digital Pathology’s Next Act: Mining Historical Data to Revolutionize Preclinical Research digital-pathologys-next-act-mining-historical-data-to-revolutionize-preclinical-research

Digital Pathology’s Next Act: Mining Historical Data to Revolutionize Preclinical Research

Nana Muazin October 8, 2026

In the landscape of modern drug discovery, a quiet revolution is unfolding within the archives of pathology...

Beyond Awareness: Global Landmarks to Shine Teal, Green, and Pink for Metastatic Breast Cancer Research

A Global Beacon: #LightUpMBC Campaign Unites World to Confront Metastatic Breast Cancer

Regulatory Shift: The End of Disparate Impact Enforcement Under Title VI

A New Frontier in Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation

Beyond the Diagnosis: Navigating Life After Breast Cancer Treatment

Biotech Industry Weekly: Market Volatility, Regulatory Shifts, and Strategic Capital Moves

A Fractured Partnership: The World Health Organization Reflects on the U.S. Withdrawal and the Lessons of the Pandemic

FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Approval of Tucatinib Maintenance Therapy

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Digital Pathology’s Next Act: Mining Historical Data to Revolutionize Preclinical Research

You may have missed

Unraveling the Colorectal Cancer Paradox: MSK Researchers Discover Dual Roles of Immune Cells, Paving Way for New Therapies

New evidence shows depression linked to circadian rhythm

A Storm of Resilience: Brenja’s Journey Through Triple-Negative Breast Cancer

Bridging the Gap: METAvivor’s 2026 Legislative Strategy and the Push for Metastatic Breast Cancer Research Reform